Regulation 88 Amendment of regulation 79 (failure to provide information on marketing authorisations to EMA)F1I1
United Kingdom
In regulation 79 (failure to provide information on marketing authorisations to EMA)—
(a)
in paragraph (1), for the first reference to “a marketing authorisation” substitute “a UKMA(NI) or UKMA(UK)”;
(b)
in paragraph (2), for the first reference to “a marketing authorisation” substitute “UKMA(NI) or UKMA(UK)”.
Annotations
Textual amendments
- F1
Reg. 88 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 65
Commencement
- I1
Reg. 88 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1